You might know about Ozempic and Wegovy, two drugs that help people feel full and eat less. With obesity rates high, a lot of Americans want these treatments. But here’s the tricky part: even though many have employer-sponsored health insurance, getting coverage for these expensive medicines is toug
Looking into how many large companies cover weight loss drugs, a recent Health Affairs survey reveals a surprising truth. Less than one in five of these big firms include popular, pricey drugs like Wegovy and Zepbound in their health plans. This leaves millions of workers without access to these med
Ever heard of a drug that can help you shed pounds while treating diabetes? Well, meet Ozempic, Wegovy, and Zepbound – the weight loss drugs taking the world by storm. Originally designed to treat diabetes, these medications have a slimming side effect that's got everyone talking. Pharmaceutical gia
Abortion drugs are often touted as a safe and convenient option for women, but the truth is far from it. As a medical professional who has researched the safety of these drugs, I have seen firsthand the devastating consequences they can have on women's lives. The case of two Georgia women who died
In the world of Hollywood, fame and fortune can be a double-edged sword. While it can bring immense joy and success, it can also lead to a life of excess and addiction. Behind the glamour and glitz, many celebrities struggle with addiction, and often, it's the doctors who prescribe and overprescribe
As the 2024 election season heats up, a new wave of Republican proposals threatens to unravel the progress made in healthcare reform. The party's aim is to repeal key provisions of the Inflation Reduction Act (IRA) and the Affordable Care Act (ACA), aiming to increase the cost of health insurance an
In the world of medicine, the cost of living with diabetes is skyrocketing, and it's not just because of the drugs themselves. A recent lawsuit filed by the Federal Trade Commission (FTC) against three major pharmacy benefit managers (PBMs) sheds light on a more sinister force driving up insulin pri
Crime is a pressing issue that affects communities nationwide, and it's no wonder that politicians from both parties are vying for attention on this topic. However, in their haste to appeal to voters, they often overlook a critical factor in crime reduction: local, data-driven solutions. Public safe
As the world becomes increasingly reliant on social media, a new and insidious threat has emerged: deepfake videos using the trusted identities of famous doctors to promote dangerous and untested miracle cures for serious health problems. The scammers are getting more sophisticated, deploying the li
Eli Lilly, the pharmaceutical giant known for its diabetes and weight-loss drugs, has made a bold move by appointing insider Lucas Montarce as their new chief financial officer. This comes months after former CFO Anat Ashkenazi left to join Google parent Alphabet. Montarce brings over two decades of
